Patient-reported severity of dry eye and quality of life in diabetes
Md Kaosar Yazdani-Ibn-Taz,1 Myint Myint Han,1 Sven Jonuscheit,1 Andrew Collier,1,2 Jane E Nally,1 Suzanne Hagan1 1School of Health and Life Sciences, Glasgow Caledonian University (GCU), Glasgow G4 0BA, UK; 2Diabetes Day Centre, University Hospital Ayr, Ayr KA6 6DX, UK Purpose: The purpose of the...
Guardado en:
Autores principales: | Yazdani-Ibn-Taz MK, Han MM, Jonuscheit S, Collier A, Nally JE, Hagan S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fd18878e8ab443eb8e0d7b4184139239 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis
por: Groß D, et al.
Publicado: (2017) -
Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study
por: McDonald MB, et al.
Publicado: (2018) -
Six months' treatment with lifitegrast in patients with moderate-to-severe symptomatic dry eye: a retrospective chart review
por: Atallah RT, et al.
Publicado: (2019) -
Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease
por: White DE, et al.
Publicado: (2020) -
Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature
por: Rhee MK, et al.
Publicado: (2017)